Skip to content
  • About
    • What we do
    • Our history
    • Our team
    • Our committees
    • Our partners
    • About genomics
  • Services
    • What we offer
    • Research we’re supporting
  • Tools & resources
    • Search all tools & resources
    • Research ethics & governance
    • Consent & patient support materials
    • Evaluating genomic research & translation
    • Data governance
    • Access our datasets
    • Data capture & standardisation
    • Data analysis & interpretation
    • Workforce education
    • Our publications
    • Our submissions
  • Our project areas
    • Our project areas
    • Genomic implementation projects 2022
    • Genomic information management
    • Clinical genomic practice
    • Genomic literacy, workforce & training
    • Indigenous genomic priorities
    • Genomic diagnostics
    • Evaluating genomic research & translation
    • Australian health system policy & practice
    • Involvement & engagement
  • News & events
    • News
    • Events
    • Personal stories
    • Search news & events
  • Connect with us

Mapping the genome of prostate cancer uncovers a new world of DNA rearrangements

Home All news & events News Mapping the genome of prostate cancer…

The study, a world first in comprehensive next-generation ‘mapping’ of an entire prostate cancer genome, was performed using the Irys®System from Bionano Genomics, Inc.

It uncovered ten times more large-scale DNA rearrangements than have previously been detected in prostate cancer. Large-scale rearrangements can include relocation of long stretches of DNA from one part of the genome to another, as well as deletions or insertions of DNA sequence at particular sites in the genome.

Professor Vanessa Hayes, Head of Garvan’s Human Comparative and Prostate Cancer Genomics Laboratory, led the study.

…continue reading at the Garvan Institute of Medical Research website.

Acknowledgement: Content reproduced with permission from the Garvan Institute of Medical Research.